Improvement in Quality of Life and Functional Status Following Valbenazine Treatment in Patients with Tardive Dyskinesia: Real-world Data from a Chart Extraction and Clinician Survey (P10-5.019)
To update and expand upon a previously completed survey and chart extraction by capturing more recent information on tardive dyskinesia (TD) burden and clinician-reported improvement with treatment across various areas, including physical, functional, social, emotional, and independence.
Authors
- Dawn Vanderhoef (ORCID: https://orcid.org/0000-0002-3301-4615)
- Rimal Bera
- Morgan Bron
- Justin Nedzesky
- Ivan Gandayuwana
- Dan Winkelman
Institutions
- University of California, Irvine (US)
- IQVIA (United Kingdom) (GB)
- Neurocrine Biosciences (United States) (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000212273
- Primary Topic
- Analytical Methods in Pharmaceuticals
- Type
- article
- Field-Weighted Citation Impact
- 0.00